Beta-O2 Technologies

Implantable Bioreactor for Treating Type 1 Diabetes

Health Tech & Life Sciences
Non Active, Aug 2025 ceased to operate
Mature Rosh Haayin, Israel Founded 2004
LinkedIn
Last updated 2026-06-18
Total raised
$8.2M
Last: 2018-01
Stage
Mature
Founded
2004
Headcount
15
HQ
Rosh Haayin, Israel
Sector
Health Tech & Life Sciences

About

Beta-O2 Technologies is a biomedical company developing a proprietary implantable bioreactor, the Air, for the treatment of patients with type 1 diabetes. The Air is a small medical device that is implanted in a minimally invasive procedure. The device, which contains islets of Langerhans, is intended to free patients from insulin injections and continuous monitoring of glucose levels. The device also reduces the risk of hypoglycemic episodes and other complications of the condition. Because the Air device contains living cells, the patient needs to refill the air in the device using a replenishing device, which includes a dedicated injector.

Funding history · 6 rounds · $8.2M total

2018-01
2015-03
Undisclosed
2014-09
Grant $1.0M
2007-02
Undisclosed
2004-03

Q&A

What is Beta-O2 Technologies' primary focus?
Beta-O2 Technologies is a biomedical company developing a proprietary implantable bioreactor, called the Air, for the treatment of patients with type 1 diabetes.
What is the current status of Beta-O2 Technologies?
Beta-O2 Technologies is currently inactive, having ceased operations in August 2025.
When was Beta-O2 Technologies founded?
Beta-O2 Technologies was founded in January 2004.
How many employees did Beta-O2 Technologies have?
Beta-O2 Technologies had 11-50 employees.
What was the total amount of funding raised by Beta-O2 Technologies?
Beta-O2 Technologies raised a total of $8,225,000 USD.
When was Beta-O2 Technologies' last funding round?
Beta-O2 Technologies' last funding round occurred in January 2018, with an amount of $25,000 USD.
Which investors participated in Beta-O2 Technologies' initial funding round in March 2004?
In March 2004, SCP Vitalife and Heznek Fund participated in Beta-O2 Technologies' funding round.
Did Beta-O2 Technologies receive any grants?
Yes, Beta-O2 Technologies received a $1,000,000 USD grant from JDRF in September 2014.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B

Highlights

1 Patents

Tags

biotechnologyminimally-invasivediabetesmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)